Benchmark restated their speculative buy rating on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Wednesday,Benzinga reports. The brokerage currently has a $1.25 price objective on the stock.
Separately, StockNews.com initiated coverage on Milestone Scientific in a report on Monday. They issued a “hold” rating for the company.
Read Our Latest Research Report on Milestone Scientific
Milestone Scientific Price Performance
Insider Transactions at Milestone Scientific
In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders have sold 109,193 shares of company stock worth $101,634. Insiders own 24.75% of the company’s stock.
Hedge Funds Weigh In On Milestone Scientific
A hedge fund recently bought a new stake in Milestone Scientific stock. Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 52,368 shares of the company’s stock, valued at approximately $48,000. Y Intercept Hong Kong Ltd owned 0.07% of Milestone Scientific as of its most recent SEC filing. Hedge funds and other institutional investors own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
- Five stocks we like better than Milestone Scientific
- Buy P&G Now, Before It Sets A New All-Time High
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- The How And Why of Investing in Oil Stocks
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What Do S&P 500 Stocks Tell Investors About the Market?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.